Clonal Distribution of Common Pneumococcal Serotypes Not Included in the 7-Valent Conjugate Vaccine (PCV7): Marked Differences between Two Ethnic Populations in Southern Israel

Pediatric Infectious Disease Unit, Soroka University Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Journal of clinical microbiology (Impact Factor: 3.99). 08/2012; 50(11):3472-7. DOI: 10.1128/JCM.01309-12
Source: PubMed


This study aimed to compare the clonal distribution of common pneumococcal strains not included in the 7-valent pneumococcal conjugate vaccine (PCV7) that were isolated from cases of acute otitis media (AOM) and invasive pneumococcal disease (IPD) in two distinct ethnic populations in southern Israel during the decade (1999 to 2008) preceding PCV7 implementation. Isolates recovered from Jewish and Bedouin children <5 years old were characterized by antibiotic resistance and molecular epidemiology using pulsed-field gel electrophoresis and multilocus sequence typing. Of 5,236 AOM and 425 IPD isolates, 43% and 57% were from Jewish and Bedouin children, respectively. PCV7 accounted for 54% and 45% of the AOM and IPD episodes, respectively. Eleven major non-PCV7 serotypes (1, 3, 5, 6A, 7F, 12F, 15B/C, 19A, 21, 33F, and 35B) constituted 31% and 42% of the AOM and IPD episodes, respectively. The clonal distributions of the 11 non-PCV7 serotypes and their antibiotic susceptibilities were significantly different among the two ethnic populations in both the AOM and IPD groups. About half of the AOM and IPD cases resulted from non-PCV7 pneumococci, even before PCV7 implementation. The significant differences between the two ethnic populations suggest that lifestyle and microenvironment are major determinants in the clonal distribution of disease-causing pneumococci. Post-PCV7 surveillance is important in understanding non-PCV7 clonal expansion in the two distinct populations.

Download full-text


Available from: Noga Givon-Lavi, Jan 01, 2014
11 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: BACKGROUND:: We aimed to determine whether serotype 1 (SP1) invasive pneumococcal disease (IPD) can be distinguished by demographic, clinical and laboratory characteristics from IPD caused by the other most common serotypes (MCS) in our region: 5, 14, 6A, 6B, 19A, 19F, 23F. METHODS:: Data for all IPD episodes in children <18 years old treated at the Soroka University Medical Center during 2000-2009 were retrospectively retrieved. Episodes caused by SP1-IPD were compared with those caused by MCS-IPD (both grouped and individual serotypes). Analyses were adjusted for age and ethnicity. RESULTS:: 94 SP1-IPD and 250 MCS-IPD episodes were documented. SP1-IPD cases were older (68.3 ± 52.6 months vs.30.4 ± 39.2 months; P< 0.001) and more likely to be found in Bedouin children than MCS-IPD (87.5% vs. 58.6%; P< 0.001). SP1 was less frequently isolated from patients with underlying disease than MCS (14.9% vs. 31.6 %; P< 0.001; RR 0.15 [95% CI: 0.07-0.32]). SP1 was more often associated with bacteremic pneumonia and primary peritonitis than MCS (70.2% vs. 38.4% and 7.4% vs. 0.8%, respectively; P< 0.001); the proportion of bacteremia without focus was higher in MCS-IPD (32.3% vs. 12.5 %; P< 0.001). There were no differences in hospitalization and mortality rates (70.2% vs. 68.0% [P = 0.22] and 4.3% vs. 5.6% [P = 0.26], respectively). CONCLUSIONS:: SP1 was found less frequently than MCS in children with underlying diseases, but was more frequent in older and Bedouin children with IPD. SP1was more frequently associated with bacteremic pneumonia and primary peritonitis than MCS grouped.
    The Pediatric Infectious Disease Journal 01/2013; DOI:10.1097/INF.0b013e31828691cb · 2.72 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: We characterized Streptococcus pneumoniae serotype 6D (Sp6D) from previously identified Sp6B among Jewish and Bedouin children in southern Israel, during a decade before vaccination. Sp6D constituted 6.7% of the presumed Sp6B. Sp6D strains belonged to 20 sequence types that were differentially distributed among the 2 ethnic groups.
    Journal of clinical microbiology 02/2013; 51(5). DOI:10.1128/JCM.03320-12 · 3.99 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: After the introduction of the 7-valent pneumococcal conjugate vaccine (PCV7) in Alaska, the incidence of invasive pneumococcal disease (IPD) due to non-vaccine serotypes, particularly serotype 19A, increased. The aim of this study was to describe the molecular epidemiology of IPD due to serotype 19A in Alaska. IPD data were collected from 1986 to 2010 through population-based laboratory surveillance. Isolates were serotyped by the Quellung reaction and MICs determined by broth microdilution. Genotypes were assessed by multilocus sequence typing. Among 3,294 cases of laboratory-confirmed IPD, 2,926 (89%) isolates were available for serotyping, of which 233 (8%) were serotype 19A. Across all ages, the proportion of IPD caused by serotype 19A increased from 3.5% (63/1823) pre-PCV7 (1986-2000) to 15.4% (170/1103) post-PCV7 (2001-2010) (p<0.001); among children <5 years of age, the proportion increased from 5.0% (39/776) to 33.0% (76/230) (p<0.001). The annual incidence rate of IPD due to serotype 19A (all ages) increased from 0.73 cases pre-PCV7 to 2.56 cases/100,000 persons post-PCV7 (p<0.001); rates among children <5 years of age increased from 4.84 cases to 14.1 cases/100,000 persons (p<0.001). Among all IPD isolates with reduced susceptibility to penicillin, 17.8% (32/180) were serotype 19A pre-PCV7 and 64% (121/189) were serotype 19A post-PCV7 (p<0.001). Eighteen different sequence types (STs) were identified; ST199 or single locus variants of ST199 (n=150) and ST172 (n=59) accounted for the majority of isolates. Multidrug-resistant isolates were clustered in ST199 and ST320. While PCV13 should significantly reduce the burden of disease due to 19A, these data highlight the need to continue surveillance for IPD to monitor the effects of vaccination on the expansion and emergence of non-PCV strains.
    08/2013; 72. DOI:10.3402/ijch.v72i0.20854
Show more